Clinical trials: Mortality Rate

Mortality, Resistance Bacterial

Azithromycin for Child Survival in Niger: Mortality and Resistance Trial

• Completed
• Age: 1 month to 59 months
• Phase 4
• Results posted

The MORDOR trial found that biannual distribution of azithromycin to children 1-59 months old reduced child mortality. The World Health Organization (WHO) released conditional guidelines for this intervention, which include…

Conditions

Mortality, Resistance Bacterial, Child, Only

Trial name

AVENIR (NCT04224987)

Testing

Azithromycin

Where

Niger

Volunteers

864,493 people, healthy volunteers welcome

Sponsor

University of California, San Francisco